Literature DB >> 20207454

Amino acid and protein metabolism in the human kidney and in patients with chronic kidney disease.

Giacomo Garibotto1, Antonella Sofia, Stefano Saffioti, Alice Bonanni, Irene Mannucci, Daniela Verzola.   

Abstract

The progressive loss of kidney function in patients with chronic kidney disease (CKD) is associated with a number of complications, including cardiovascular diseases, anemia, hyperparathyroidism, inflammation, metabolic acidosis, malnutrition and protein-energy wasting. The excess cardiovascular risk related to CKD is due in part to a higher prevalence of traditional atherosclerotic risk factors, in part to non-traditional, emerging risk factors peculiar to CKD. While even minor renal dysfunction is an independent predictor of adverse cardiovascular prognosis, nutritional changes are more often observed in an advanced setting. In addition, factors related to renal-replacement treatment may be implicated in the pathogenesis of heart disease and protein-energy wasting in dialysis-treated patients. Progressive alterations in kidney metabolism may cause progressive effects on cardiovascular status and nutrition. Altered kidney amino acid/protein metabolism and or excretion may be a key factor in the homeostasis of several vasoactive compounds and hormones in patients with more advanced disease. In this discussion recent research regarding the kidney handling of amino acids and protein turnover and their potential link with cardiovascular disease, progressive kidney dysfunction and nutritional status are reviewed. Copyright 2010 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20207454     DOI: 10.1016/j.clnu.2010.02.005

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  25 in total

1.  Relationship between dietary protein intake and the changes in creatinine clearance and glomerular cross-sectional area in patients with IgA nephropathy.

Authors:  Toshikazu Wada; Toshiyuki Nakao; Hiroshi Matsumoto; Tomonari Okada; Yume Nagaoka; Hideaki Iwasawa; Asako Gondo; Ami Niwata; Yoshihiko Kanno
Journal:  Clin Exp Nephrol       Date:  2014-11-16       Impact factor: 2.801

2.  In vivo toxicometabolomics reveals multi-organ and urine metabolic changes in mice upon acute exposure to human-relevant doses of 3,4-methylenedioxypyrovalerone (MDPV).

Authors:  Ana Margarida Araújo; Márcia Carvalho; Vera Marisa Costa; José Alberto Duarte; Ricardo Jorge Dinis-Oliveira; Maria de Lourdes Bastos; Paula Guedes de Pinho; Félix Carvalho
Journal:  Arch Toxicol       Date:  2020-11-19       Impact factor: 5.153

3.  Higher protein intake is associated with increased risk for incident end-stage renal disease among blacks with diabetes in the Southern Community Cohort Study.

Authors:  R Malhotra; K L Cavanaugh; W J Blot; T A Ikizler; L Lipworth; E K Kabagambe
Journal:  Nutr Metab Cardiovasc Dis       Date:  2016-07-21       Impact factor: 4.222

4.  Plasma and urinary amino acid metabolomic profiling in patients with different levels of kidney function.

Authors:  Flore Duranton; Ulrika Lundin; Nathalie Gayrard; Harald Mischak; Michel Aparicio; Georges Mourad; Jean-Pierre Daurès; Klaus M Weinberger; Angel Argilés
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 8.237

5.  Nutritional predictors of early mortality in incident hemodialysis patients.

Authors:  Lilia R Lukowsky; Leeka Kheifets; Onyebuchi A Arah; Allen R Nissenson; Kamyar Kalantar-Zadeh
Journal:  Int Urol Nephrol       Date:  2013-05-24       Impact factor: 2.370

Review 6.  Effect of restricted protein diet supplemented with keto analogues in end-stage renal disease: a systematic review and meta-analysis.

Authors:  Zheng Jiang; Yi Tang; Lichuan Yang; Xuhua Mi; Wei Qin
Journal:  Int Urol Nephrol       Date:  2017-10-03       Impact factor: 2.370

7.  Absorption, distribution, metabolism and excretion of peginesatide, a novel erythropoiesis-stimulating agent, in rats.

Authors:  Kathryn W Woodburn; Christopher P Holmes; Susan D Wilson; Kei-Lai Fong; Randall J Press; Yuu Moriya; Yoshihiko Tagawa
Journal:  Xenobiotica       Date:  2011-12-22       Impact factor: 1.908

8.  Hematopoietic stem cell transplantation induces immunologic tolerance in renal transplant patients via modulation of inflammatory and repair processes.

Authors:  Duojiao Wu; Guisheng Qi; Xuanchuan Wang; Ming Xu; Ruiming Rong; Xiangdong Wang; Tongyu Zhu
Journal:  J Transl Med       Date:  2012-08-31       Impact factor: 5.531

Review 9.  Protein-energy wasting and mortality in chronic kidney disease.

Authors:  Alice Bonanni; Irene Mannucci; Daniela Verzola; Antonella Sofia; Stefano Saffioti; Ezio Gianetta; Giacomo Garibotto
Journal:  Int J Environ Res Public Health       Date:  2011-05-19       Impact factor: 3.390

10.  Altered Amino Acid Metabolism in Patients with Cardiorenal Syndrome Type 2: Is It a Problem for Protein and Exercise Prescriptions?

Authors:  Roberto Aquilani; Roberto Maestri; Maurizia Dossena; Maria Teresa La Rovere; Daniela Buonocore; Federica Boschi; Manuela Verri
Journal:  Nutrients       Date:  2021-05-13       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.